As previously reported in other type of cancers, our study indicated that NPC patients with high NKILA expression survived significantly longer (OS, P < 0.001) or longer DFS (P < 0.001) [21, 31, 32]. The gene discussed is NKILA; the disease is nasopharyngeal carcinoma.